Free Webex Call
The Vitamin B1 Market was valued at USD 301.68 Million in 2024, and is expected to reach USD 447.60 Million by 2030, rising at a CAGR of 4.81%. Vitamin B1, also known as thiamine, is a crucial water-soluble vitamin essential for carbohydrate metabolism and proper nervous system functioning. Its wide-ranging applications in human and animal health have established its importance across various sectors.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
In animal nutrition, Vitamin B1 is increasingly used in livestock and aquaculture feeds to support healthy development and metabolic performance. The growing global demand for meat, alongside heightened awareness of animal wellness, particularly in emerging economies such as those in Asia Pacific and North America, is expected to sustain the demand for vitamin-enriched feed. However, challenges such as raw material price volatility, regulatory compliance issues, and the circulation of counterfeit products may impact production efficiency and consumer confidence.
Key Market Drivers
Growth in Pharmaceutical Industry
The sustained expansion of the global pharmaceutical industry is a primary driver of the Vitamin B1 (thiamine) market. With global pharmaceutical revenues reaching approximately USD 1.6 trillion in 2023, Vitamin B1's role in supporting nerve function, energy metabolism, and treating various deficiencies has become increasingly prominent. Its inclusion in multivitamin supplements, injectables, and therapeutic formulations is rising in response to growing incidences of vitamin deficiencies and chronic illnesses. A notable example is Lupin's 2023 launch of Thiamine Hydrochloride Injection USP, developed in partnership with Caplin Steriles Limited, following FDA approval. Vitamin B1 continues to be prescribed for conditions like beriberi and Wernicke-Korsakoff syndrome, particularly in at-risk populations such as those with diabetes or alcohol dependency, further strengthening its demand within pharmaceutical applications.Key Market Challenges
High Cost of Thiamine Mononitrate
The elevated cost of thiamine mononitrate remains a critical hurdle for the Vitamin B1 market. As a stable and effective synthetic form of Vitamin B1, thiamine mononitrate is widely used in dietary supplements and fortified foods. However, its complex production process and the need for rigorous quality control drive up its manufacturing costs. Variations in raw material availability, reliance on chemical intermediates, and adherence to strict environmental and safety regulations contribute to its high pricing. These cost pressures pose challenges for market expansion, particularly in price-sensitive regions, and can limit broader adoption across food and pharmaceutical sectors.Key Market Trends
Rising Demand of Vitamin B1 from the Animal Nutrition Segment
The animal nutrition sector is becoming a vital contributor to the growth of the global Vitamin B1 market. As nations like India experience population growth and higher income levels, the consumption of animal-based foods is expected to rise, thereby boosting the demand for nutrient-fortified animal feed. Vitamin B1 plays a pivotal role in maintaining energy metabolism and neurological health in animals, which in turn improves growth performance and disease resistance. Feed manufacturers and livestock producers are increasingly adding thiamine to formulations to enhance productivity and reduce metabolic health issues, thereby supporting overall profitability and operational efficiency.Key Market Players
- HUAZHONG PHARMACEUTICAL CO., LTD.
- Brother Enterprises Holding Co.
- Jiangxi Tianxin Pharmaceutical Co., Ltd
- dsm-firmenich
- Medikonda Nutrients
Report Scope
In this report, the Global Vitamin B1 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Vitamin B1 Market, By Sales Channel:
- Direct
- Indirect
Vitamin B1 Market, By End Use:
- Pharmaceutical
- Feed Additives
- Food Additives
- Dairy Products
- Others
Vitamin B1 Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B1 Market.Available Customizations
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Vitamin B1 Market Outlook
6. North America Vitamin B1 Market Outlook
7. Europe Vitamin B1 Market Outlook
8. Asia Pacific Vitamin B1 Market Outlook
9. South America Vitamin B1 Market Outlook
10. Middle East and Africa Vitamin B1 Market Outlook
11. Market Dynamics
12. Market Trends & Developments
14. Porters Five Forces Analysis
15. Competitive Landscape
Companies Mentioned
- HUAZHONG PHARMACEUTICAL CO., LTD.
- Brother Enterprises Holding Co.
- Jiangxi Tianxin Pharmaceutical Co., Ltd
- dsm-firmenich
- Medikonda Nutrients
